KRAS and neoplasm: First, we determined that the KRAS mutant allele frequency (MAF) positivity threshold was 0.72%, using non-tumour DNA extracted from formol-fixed paraffin-embedded (FFPE) healthy tissue samples with proven KRASWT status by NGS.